Ocumension Therapeutics OCUTF
$0.70
Last Updated: Jun 08, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Ocumension Therapeutics. Stock Analysis OCUTF
United States Health Care Small Cap Ocumension Therapeutics engages in the identification, development, and commercialization of ophthalmic therapies. The company is headquartered in Suzhou, Jiangsu and currently employs 552 full-time employees. The company went IPO on 2020-07-10. The products primarily include OT-401 Yutiq fluocinolone intravitreal implant, OT-702 Boyoujing aflibercept intravitreous injection, OT-402 Visudyne, OT- 204 Ou Qin sodium hyaluronate eye drops and OT-305 Betoptic S betaxolol hydrochloride and others. The products are used to treat various anterior and posterior segment eye diseases, such as uveitis, fundus diseases, refractive correction, dry eye disease (DED), glaucoma and conjunctivitis. The firm primarily operates its business in the domestic market.
Ocumension Therapeutics (OCUTF) Chart
Financial Metrics & Statements of Ocumension Therapeutics (OCUTF)
FAQ's for Ocumension Therapeutics (OCUTF)
- As of August 2026, Ocumension Therapeutics OCUTF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Ocumension Therapeutics using these criteria to determine its compliance status.
- Muslim investors may consider investing in Ocumension Therapeutics if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Ocumension Therapeutics by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Ocumension Therapeutics may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Ocumension Therapeutics on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Ocumension Therapeutics (OCUTF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
